#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	132	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c4.ctg.1	811	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAC(2')-Ic;b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis."
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T606G	SNP	606	606	T	15	15	G	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T608G	SNP	608	608	T	17	17	G	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T618C	SNP	618	618	T	27	27	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T619A	SNP	619	619	T	28	28	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T624A	SNP	624	624	T	33	33	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	A630C	SNP	630	630	A	39	39	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T633C	SNP	633	633	T	42	42	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	A642C	SNP	642	642	A	51	51	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	G657T	SNP	657	657	G	66	66	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	A692G	SNP	692	692	A	101	101	G	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T706G	SNP	706	706	T	115	115	G	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T717G	SNP	717	717	T	126	126	G	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	C720A	SNP	720	720	C	129	129	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	C758A	SNP	758	758	C	167	167	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T782C	SNP	782	782	T	191	191	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	C810T	SNP	810	810	C	219	219	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	A812C	SNP	812	812	A	221	221	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	C818T	SNP	818	818	C	227	227	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T822A	SNP	822	822	T	231	231	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T842A	SNP	842	842	T	251	251	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	C902G	SNP	902	902	C	311	311	G	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	C925T	SNP	925	925	C	334	334	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	26	Cutibacterium_acnes_16S	1486	375	92.0	Cutibacterium_acnes_16S.l15.c30.ctg.1	398	0.0	0	.	n	.	0	T947A	SNP	947	947	T	356	356	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	90	Erm_37_	540	540	100.0	Erm_37_.l15.c4.ctg.1	970	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Erm(37);b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.'
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	1	92	Mycobacterium_tuberculosis_16S_4	1537	1009	100.0	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.1	1200	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	1	92	Mycobacterium_tuberculosis_16S_4	1537	437	100.0	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.2	463	0.0	1	SNP	n	A1401G	0	.	.	1401	1401	A	301	301	A	ND	ND	ND	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921:0:0:A1401G:.:b"Point mutations in the 3' domain of 16S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin."	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	0	0	517	164	Mycobacterium_tuberculosis_23S	3138	801	99.75	Mycobacterium_tuberculosis_23S.l15.c30.ctg.1	801	0.0	0	.	n	.	0	C807G	SNP	807	807	C	635	635	G	ND	ND	ND	.	b'Point mutations in 23S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin.';Mycobacterium tuberculosis 23S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	0	0	517	164	Mycobacterium_tuberculosis_23S	3138	801	99.75	Mycobacterium_tuberculosis_23S.l15.c30.ctg.1	801	0.0	0	.	n	.	0	C895G	SNP	895	895	C	723	723	G	ND	ND	ND	.	b'Point mutations in 23S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin.';Mycobacterium tuberculosis 23S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	0	0	517	164	Mycobacterium_tuberculosis_23S	3138	2394	99.87	Mycobacterium_tuberculosis_23S.l15.c30.ctg.2	2460	0.0	0	.	n	.	0	T908A	SNP	908	908	T	164	164	A	ND	ND	ND	.	b'Point mutations in 23S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin.';Mycobacterium tuberculosis 23S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	0	0	517	164	Mycobacterium_tuberculosis_23S	3138	2394	99.87	Mycobacterium_tuberculosis_23S.l15.c30.ctg.2	2460	0.0	0	.	n	.	0	C1275G	SNP	1275	1275	C	531	531	G	ND	ND	ND	.	b'Point mutations in 23S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin.';Mycobacterium tuberculosis 23S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	Mycobacterium_tuberculosis_23S.3004937.AL123456.3.1473657_1476795.6024	0	0	517	164	Mycobacterium_tuberculosis_23S	3138	2394	99.87	Mycobacterium_tuberculosis_23S.l15.c30.ctg.2	2460	0.0	0	.	n	.	0	C1599G	SNP	1599	1599	C	855	855	G	ND	ND	ND	.	b'Point mutations in 23S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin.';Mycobacterium tuberculosis 23S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	294	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c17.ctg.1	2010	0.0	1	SNP	p	V219A	0	.	.	655	657	GTC	1023	1025	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:V219A:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	294	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c17.ctg.1	2010	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	1242	1244	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	R268H	1	R268H	NONSYN	802	804	CGC	1066	1068	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	301	303	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	316	318	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	412	414	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	592	594	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1162	1164	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1201	1203	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	539	288	Mycobacterium_tuberculosis_ndh	1392	1392	99.93	Mycobacterium_tuberculosis_ndh.l15.c17.ctg.1	2107	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1279	1281	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C69T	SNP	69	69	C	133	133	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	.75A	INS	75	75	G	140	140	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G77A	SNP	77	77	G	142	142	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T129C	SNP	129	129	T	194	194	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C174G	SNP	174	174	C	239	239	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C176A	SNP	176	176	C	241	241	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T178G	SNP	178	178	T	243	243	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G183T	SNP	183	183	G	248	248	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A186T	SNP	186	186	A	251	251	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C193G	SNP	193	193	C	258	258	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	.196GC	INS	196	196	A	262	262	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T202A	SNP	202	202	T	269	269	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T249C	SNP	249	249	T	316	316	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C254T	SNP	254	254	C	321	321	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A291T	SNP	291	291	A	358	358	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A392G	SNP	392	392	A	459	459	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T428C	SNP	428	428	T	495	495	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G431C	SNP	431	431	G	498	498	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	.438GTC	INS	438	438	G	506	506	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A441G	SNP	441	441	A	520	520	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G444T	SNP	444	444	G	523	523	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C453G	SNP	453	453	C	532	532	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A456G	SNP	456	456	A	535	535	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C457G	SNP	457	457	C	536	536	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G466C	SNP	466	466	G	545	545	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C509G	SNP	509	509	C	588	588	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A575T	SNP	575	575	A	654	654	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A581G	SNP	581	581	A	660	660	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G593A	SNP	593	593	G	672	672	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T741G	SNP	741	741	T	820	820	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T863C	SNP	863	863	T	942	942	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	974	94.44	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A870G	SNP	870	870	A	949	949	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1086C	SNP	1086	1086	T	80	80	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1098A	SNP	1098	1098	G	92	92	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1099C	SNP	1099	1099	G	93	93	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	C1107T	SNP	1107	1107	C	101	101	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1119A	SNP	1119	1119	G	113	113	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1211G	SNP	1211	1211	A	205	205	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1217A	SNP	1217	1217	G	211	211	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1228T	SNP	1228	1228	A	222	222	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1233C	SNP	1233	1233	T	227	227	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1234G	SNP	1234	1234	A	228	228	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1239T	SNP	1239	1239	G	233	233	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1240A	SNP	1240	1240	G	234	234	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	C1250T	SNP	1250	1250	C	244	244	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1252A	SNP	1252	1252	T	246	246	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1258C	SNP	1258	1258	T	252	252	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1274C	SNP	1274	1274	T	268	268	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1295G	SNP	1295	1295	A	289	289	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1419C	SNP	1419	1419	T	413	413	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1420G	SNP	1420	1420	T	414	414	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	1	SNP	n	A1375G	0	.	.	1375	1375	A	369	369	A	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:A1375G:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	1	SNP	n	C1376U	0	.	.	1376	1376	C	370	370	C	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:C1376U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	50	Mycobacteroides_abscessus_16S_4	1504	498	95.38	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	531	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	452	452	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	.47T	INS	47	47	G	131	131	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C49T	SNP	49	49	C	133	133	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G57A	SNP	57	57	G	142	142	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C108T	SNP	108	108	C	193	193	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T109C	SNP	109	109	T	194	194	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A153G	SNP	153	153	A	238	238	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C156A	SNP	156	156	C	241	241	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T158G	SNP	158	158	T	243	243	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G165T	SNP	165	165	G	250	250	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A166T	SNP	166	166	A	251	251	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C173G	SNP	173	173	C	258	258	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	.176GC	INS	176	176	A	262	262	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T182A	SNP	182	182	T	269	269	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A227G	SNP	227	227	A	314	314	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T229C	SNP	229	229	T	316	316	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C234T	SNP	234	234	C	321	321	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A271T	SNP	271	271	A	358	358	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A372G	SNP	372	372	A	459	459	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T408C	SNP	408	408	T	495	495	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G411C	SNP	411	411	G	498	498	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	.420GGTTCTCTC	INS	420	420	G	511	511	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A422G	SNP	422	422	A	521	521	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G424T	SNP	424	424	G	523	523	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C434G	SNP	434	434	C	533	533	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C437G	SNP	437	437	C	536	536	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G446C	SNP	446	446	G	545	545	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	C489G	SNP	489	489	C	588	588	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A555T	SNP	555	555	A	654	654	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A561G	SNP	561	561	A	660	660	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G573A	SNP	573	573	G	672	672	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T721G	SNP	721	721	T	820	820	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	T843C	SNP	843	843	T	942	942	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A850G	SNP	850	850	A	949	949	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	G947A	SNP	947	947	G	1046	1046	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	963	94.08	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	1062	0.0	0	.	n	.	0	A956G	SNP	956	956	A	1055	1055	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	C1065T	SNP	1065	1065	C	79	79	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1066C	SNP	1066	1066	T	80	80	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1079C	SNP	1079	1079	G	93	93	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	C1086G	SNP	1086	1086	C	100	100	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	C1087T	SNP	1087	1087	C	101	101	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1098G	SNP	1098	1098	A	112	112	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1099A	SNP	1099	1099	G	113	113	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1191G	SNP	1191	1191	A	205	205	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1197A	SNP	1197	1197	G	211	211	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1208T	SNP	1208	1208	A	222	222	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1214G	SNP	1214	1214	A	228	228	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	G1220A	SNP	1220	1220	G	234	234	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	C1230T	SNP	1230	1230	C	244	244	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1232A	SNP	1232	1232	T	246	246	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1238C	SNP	1238	1238	T	252	252	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1254C	SNP	1254	1254	T	268	268	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	A1275G	SNP	1275	1275	A	289	289	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1397C	SNP	1397	1397	T	411	411	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	0	.	n	.	0	T1400G	SNP	1400	1400	T	414	414	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	513	50	Mycobacteroides_chelonae_16S_4	1441	455	95.16	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	531	0.0	1	SNP	n	A1355G	0	.	.	1355	1355	A	369	369	A	ND	ND	ND	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271:0:0:A1355G:.:b'Point mutations in the 16S rRNA of Mycobacteroides chelonae can cause resistance to neomycin.'	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	198	blaC	924	924	100.0	blaC.l15.c4.ctg.1	1259	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.';blaC
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	372	efpA	1593	1593	100.0	efpA.l15.c17.ctg.1	2075	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	efpA;b'efpA is an MFS transporter found in Mycobacterium tuberculosis.'
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	P913S	1	P913S	NONSYN	2737	2739	CCG	2875	2877	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	148	150	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	151	153	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	739	741	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1099	1101	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1186	1188	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1522	1524	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	534	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3582	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2635	2637	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	E378A	1	E378A	NONSYN	1132	1134	GAG	1339	1341	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	922	924	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	925	927	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	1096	1098	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	1102	1104	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1123	1125	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1123	1125	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1123	1125	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1123	1125	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1138	1140	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1162	1164	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1162	1164	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1189	1191	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1189	1191	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1195	1197	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1204	1206	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1207	1209	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1273	1275	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1276	1278	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1309	1311	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1330	1332	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1345	1347	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1396	1398	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1402	1404	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1423	1425	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1423	1425	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1423	1425	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1423	1425	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1444	1446	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1543	1545	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1585	1587	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1600	1602	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1612	1614	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1618	1620	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1696	1698	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1696	1698	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1717	1719	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1726	1728	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2440	2442	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	3082	3084	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3205	3207	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	539	638	embB_1	3297	3297	99.97	embB_1.l6.c4.ctg.1	3829	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3277	3279	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	T270I	1	T270I	NONSYN	808	810	ACC	1013	1015	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	N394D	1	N394D	NONSYN	1180	1182	AAC	1385	1387	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	944	946	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	956	958	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	965	967	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	1058	1060	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	1064	1066	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	1067	1069	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	1067	1069	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1091	1093	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1091	1093	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1094	1096	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1094	1096	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1103	1105	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1109	1111	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1112	1114	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1124	1126	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1127	1129	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1130	1132	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1133	1135	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1178	1180	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1181	1183	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1184	1186	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1397	1399	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1676	1678	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1709	1711	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	R738Q	0	.	.	2212	2214	CGG	2417	2419	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	584	embC	3285	3285	99.91	embC.l15.c4.ctg.1	3664	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3146	3148	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	539	292	embR	1167	1167	99.91	embR.l15.c17.ctg.1	1859	0.0	1	SNP	p	C110Y	1	C110Y	NONSYN	328	330	TGC	727	729	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	539	292	embR	1167	1167	99.91	embR.l15.c17.ctg.1	1859	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1534	1536	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	N345K	1	N345K	NONSYN	1033	1035	AAC	1109	1111	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	158	160	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	179	181	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	200	202	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	242	244	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	248	250	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	281	283	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	380	382	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	497	499	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	611	613	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	632	634	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	641	643	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	812	814	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	836	838	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	875	877	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1061	1063	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1097	1099	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1130	1132	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1190	1192	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1259	1261	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1283	1285	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	398	ethA_2	1470	1470	99.86	ethA_2.l15.c4.ctg.1	1994	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1514	1516	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	370	372	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	430	432	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	430	432	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	439	441	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	439	441	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	439	441	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	457	459	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	457	459	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	478	480	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	583	585	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	760	762	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	760	762	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	769	771	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	769	771	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	204	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2104	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1570	1572	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	531	158	gidB	675	675	99.41	gidB.l15.c4.ctg.1	1209	0.0	0	.	p	.	0	G34fs	FSHIFT	100	100	G	253	253	G	ND	ND	ND	.	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	531	158	gidB	675	675	99.41	gidB.l15.c4.ctg.1	1209	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	241	243	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	400	402	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	622	624	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	0	.	p	.	0	A384V	NONSYN	1150	1152	GCA	1489	1491	GTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2341	2343	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	559	561	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	577	579	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	601	603	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	601	603	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	604	606	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	604	606	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	604	606	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	607	609	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	607	609	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	610	612	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	619	621	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	619	621	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	619	621	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	619	621	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	619	621	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	619	621	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	532	gyrA_1	2517	2517	99.8	gyrA_1.l15.c30.ctg.1	3293	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	643	645	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	0	.	p	.	0	M330I	NONSYN	988	990	ATG	1402	1404	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1432	1434	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	1912	1914	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	2026	2028	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	2026	2028	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	2029	2031	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	2029	2031	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	2032	2034	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	614	gyrB_6	2145	2145	99.91	gyrB_6.l15.c4.ctg.1	2811	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	2032	2034	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	179	181	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	194	196	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	194	196	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	272	274	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	365	367	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	413	415	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	416	418	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	554	556	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	128	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1217	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	713	715	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	448	iniA	1923	1923	99.95	iniA.l15.c4.ctg.1	2344	0.0	0	.	p	.	0	H481Q	NONSYN	1441	1443	CAT	1530	1532	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	448	iniA	1923	1923	99.95	iniA.l15.c4.ctg.1	2344	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	96	98	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	448	iniA	1923	1923	99.95	iniA.l15.c4.ctg.1	2344	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1011	1013	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	448	iniA	1923	1923	99.95	iniA.l15.c4.ctg.1	2344	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1590	1592	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	448	iniA	1923	1923	99.95	iniA.l15.c4.ctg.1	2344	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1698	1700	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	27	212	iniB	1440	1440	100.0	iniB.l6.c4.ctg.1	1976	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	536	538	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	539	308	iniC	1482	1482	99.87	iniC.l15.c4.ctg.1	2157	0.0	0	.	p	.	0	R476C	NONSYN	1426	1428	CGC	1802	1804	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	539	308	iniC	1482	1482	99.87	iniC.l15.c4.ctg.1	2157	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	623	625	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	539	308	iniC	1482	1482	99.87	iniC.l15.c4.ctg.1	2157	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	1118	1120	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	198	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1743	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	564	566	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	198	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1743	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	729	731	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	198	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1743	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	1173	1175	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	198	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1743	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1302	1304	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	198	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1743	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1527	1529	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	198	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1743	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1605	1607	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	S315T	1	S315T	NONSYN	943	945	AGC	1257	1259	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1701	1703	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	411	413	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	585	587	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	642	644	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	645	647	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	687	689	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	690	692	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	693	695	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	738	740	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	753	755	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1104	1106	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1248	1250	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1563	1565	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1695	1697	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1782	1784	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1836	1838	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2133	2135	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	518	katG_1	2223	2223	99.91	katG_1.l15.c4.ctg.1	2718	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2292	2294	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	130	mfpA	552	552	100.0	mfpA.l15.c30.ctg.1	1399	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.';mfpA
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	27	208	mshA_1	1443	1443	100.0	mshA_1.l15.c4.ctg.1	1665	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1155	1157	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	298	murA_4	1257	1257	100.0	murA_4.l15.c4.ctg.1	1649	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	570	572	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	188	190	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	194	196	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	197	199	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	200	202	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	206	208	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	206	208	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	206	208	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	209	211	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	212	214	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	212	214	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	215	217	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	215	217	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	215	217	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	221	223	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	221	223	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	221	223	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	227	229	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	227	229	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	236	238	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	236	238	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	242	244	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	254	256	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	263	265	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	266	268	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	287	289	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	308	310	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	320	322	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	323	325	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	323	325	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	326	328	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	326	328	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	326	328	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	332	334	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	332	334	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	338	340	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	338	340	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	344	346	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	347	349	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	347	349	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	356	358	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	356	358	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	359	361	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	371	373	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	383	385	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	386	388	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	389	391	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	389	391	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	389	391	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	389	391	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	389	391	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	392	394	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	398	400	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	401	403	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	401	403	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	413	415	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	413	415	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	419	421	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	431	433	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	440	442	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	440	442	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	455	457	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	467	469	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	473	475	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	473	475	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	473	475	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	473	475	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	476	478	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	485	487	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	491	493	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	491	493	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	494	496	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	494	496	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	497	499	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	533	535	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	539	541	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	542	544	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	548	550	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	560	562	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	581	583	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	584	586	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	587	589	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	590	592	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	593	595	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	593	595	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	593	595	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	596	598	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	596	598	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	599	601	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	599	601	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	599	601	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	602	604	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	602	604	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	602	604	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	605	607	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	608	610	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	611	613	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	611	613	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	623	625	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	647	649	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	650	652	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	656	658	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	662	664	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	665	667	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	668	670	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	668	670	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	677	679	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	689	691	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	698	700	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	698	700	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	698	700	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	701	703	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	701	703	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	707	709	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	710	712	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	725	727	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	156	pncA	561	561	100.0	pncA.l15.c4.ctg.1	952	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	731	733	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	156	ribD	777	777	100.0	ribD.l15.c4.ctg.1	1568	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	447	449	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	772	774	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1684	1686	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1849	1851	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1858	1860	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1858	1860	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1858	1860	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1858	1860	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1858	1860	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1867	1869	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1882	1884	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	736	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4148	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1912	1914	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	618	620	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1221	1223	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1224	1226	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1272	1274	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1275	1277	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1278	1280	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1281	1283	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	346	rpsA	1446	1446	100.0	rpsA.l15.c17.ctg.1	1930	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1302	1304	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	154	rpsL	375	375	100.0	rpsL.l15.c30.ctg.1	1225	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	407	409	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	154	rpsL	375	375	100.0	rpsL.l15.c30.ctg.1	1225	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	416	418	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	154	rpsL	375	375	100.0	rpsL.l15.c30.ctg.1	1225	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	551	553	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	154	rpsL	375	375	100.0	rpsL.l15.c30.ctg.1	1225	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	551	553	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	288	290	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	330	332	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	447	449	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	453	455	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	471	473	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	495	497	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	525	527	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	537	539	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	600	602	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	678	680	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	705	707	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	828	830	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	843	845	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	894	896	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	202	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1401	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	927	929	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	322	324	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	481	483	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	487	489	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	553	555	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	634	636	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	664	666	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	730	732	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	829	831	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	835	837	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	988	990	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	188	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1239	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	994	996	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
